Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 4:20 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:16 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:13 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-07-13 Option Award |
2022-07-15 6:00 pm |
N/A 2032-07-12 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
19,000 | $0 | 19,000 (Direct) |
View |
Ownership |
2022-06-15 6:01 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
0 | $0 | 194,858 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 5:11 pm |
N/A 2031-06-08 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-05-12 8:15 pm |
N/A N/A |
Orion Biotech Opportunities Corp. | ORIA | Collins James J. Director |
0 | $0 | 40,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:15 pm |
N/A 2030-06-10 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
9,285 | $0 | 9,285 (Direct) |
View |